Delivery Order SPE2DB22D3004-SPE2DB25FQF85
Award Date
4/11/25
Potential Completion Date
4/14/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,992.16, is for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has a period of performance through February 10, 2025 and does not include any set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has a ceiling value of $1,416.30 and a period of performance through April 10, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside for any specific business type. This delivery order is part of a larger...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine, with a ceiling value of $7,223.13 and an ultimate completion date of March 4, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the procurement of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has a ceiling value of $1,030.50 and a period of performance through February 2024. This award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,646.80 firm-fixed-price contract is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine, with a completion date of February 16, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $11,039.66, is for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has a firm fixed price and is set to expire on July 9, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a total ceiling value of $1,423.71 and an ultimate completion date of September 24, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, with a ceiling value of $1,937.67 and a period of performance through May 15, 2025. The contract is a firm fixed-price delivery order and is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The delivery order has a ceiling value of $1,111.55 and a completion date of August 14, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999 through December 2025 for delivering a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,646.80, is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has a firm fixed price pricing type and an ultimate completion date of March 17, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between...